Public Employees Retirement System of Ohio acquired a new stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 54,224 shares of the company's stock, valued at approximately $10,144,000. Public Employees Retirement System of Ohio owned 0.07% of Tenet Healthcare at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the business. Norges Bank acquired a new position in shares of Tenet Healthcare in the fourth quarter valued at approximately $248,494,000. Wellington Management Group LLP grew its position in Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company's stock valued at $225,706,000 after buying an additional 1,042,260 shares during the last quarter. Manning & Napier Advisors LLC acquired a new position in Tenet Healthcare in the 2nd quarter valued at $168,761,000. Boston Partners raised its position in Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company's stock worth $638,958,000 after buying an additional 880,413 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company's stock worth $380,989,000 after acquiring an additional 720,160 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.
Tenet Healthcare Stock Performance
THC opened at $265.83 on Tuesday. Tenet Healthcare Corporation has a 1-year low of $157.58 and a 1-year high of $283.05. The stock has a market cap of $21.40 billion, a P/E ratio of 10.25, a P/E/G ratio of 1.02 and a beta of 1.23. The stock's 50 day simple moving average is $231.73 and its 200 day simple moving average is $210.16. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts' consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare's quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts anticipate that Tenet Healthcare Corporation will post 20.98 EPS for the current fiscal year.
Insider Activity
In other Tenet Healthcare news, Director Tammy Romo sold 4,922 shares of Tenet Healthcare stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the completion of the transaction, the director owned 30,784 shares in the company, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Paola M. Arbour sold 10,878 shares of the stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.90, for a total transaction of $2,653,144.20. Following the completion of the sale, the executive vice president owned 18,413 shares in the company, valued at $4,490,930.70. This represents a 37.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 84,037 shares of company stock worth $22,574,292 in the last three months. Company insiders own 0.97% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on THC. Raymond James Financial reissued an "outperform" rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Friday, August 14th. Cantor Fitzgerald reiterated an "overweight" rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Guggenheim raised their price target on Tenet Healthcare from $242.00 to $283.00 and gave the company a "buy" rating in a report on Tuesday, July 28th. Zacks Research raised Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. Finally, Truist Financial boosted their target price on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a "buy" rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $273.00.
View Our Latest Report on THC
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report